Original Research

Published on 06 Apr 2023

Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience

in Cardio-Oncology

Junjuan Xiao
Xingyu Li
Xuan Wang
Yaping Guan
Hairong Liu
Jing Liang
Yan Li
Baocheng Wang
Jun Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1093383

2,853 views
5 citations

Original Research

Published on 29 Mar 2023

Early detection and serial monitoring during chemotherapy-radiation therapy: Using T1 and T2 mapping cardiac magnetic resonance imaging

in Cardio-Oncology

Yaotian Tian
Teng Wang
Liwen Tian
Yucheng Yang
Chen Xue
Wei Sheng
Cuiyan Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1085737

1,307 views
2 citations

Review

Published on 20 Mar 2023

Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity

in Cardio-Oncology

Ziji Cheng
Wanting Qin
Shaoling Li
Shuijin Shao
Baonian Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1152436

2,821 views
1 citation

Case Report

Published on 14 Mar 2023

Case report: Diagnosis, management and evolution of a bulky and invasive cardiac mass complicated by complete atrioventricular block

in Cardio-Oncology

Yohann Bohbot
Jérôme Garot
Isabelle Danjon
Dominique Thébert
Louis Nahory
Philippe Gros
Fiorella Salerno
Philippe Garot

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1135233

1,169 views

Review

Published on 10 Mar 2023

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play

in Cardio-Oncology

Maryam Moossavi
Xiaoguang Lu
Joerg Herrmann
Xiaolei Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1080299

2,828 views

Correction

Published on 09 Mar 2023

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story

in Cardio-Oncology

Irma Bisceglia
Maria Laura Canale
Giuseppina Gallucci
Fabio Maria Turazza
Chiara Lestuzzi
Iris Parrini
Giulia Russo
Nicola Maurea
Vincenzo Quagliariello
Stefano Oliva

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1169176

946 views
1 citation

Original Research

Published on 09 Mar 2023

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity

in Cardio-Oncology

Emma L. Robinson
Pietro Ameri
Leen Delrue
Marc Vanderheyden
Jozef Bartunek
Paola Altieri
Stephane Heymans
Ward A. Heggermont

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.884174

2,722 views
5 citations

Review

Published on 07 Mar 2023

Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022

in Cardio-Oncology

Di Xiao
Jingen Li
Yong Liu
Tangshun Wang
Chaofeng Niu
Rui Zhuang
Birong Liu
Liyong Ma
Meng Li
Lijing Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1089916

3,301 views
3 citations

Original Research

Published on 03 Mar 2023

Association between thyroid cancer and cardiovascular disease: A meta-analysis

in Cardio-Oncology

Wen-Hsuan Tsai
Yi-Hong Zeng
Chun-Chuan Lee
Ming-Nan Chien
Sung-Chen Liu
Kuo-Liong Chien
Shih-Ping Cheng
Po-Jung Tseng
Ming-Chieh Tsai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1075844

3,440 views
2 citations

Case Report

Published on 01 Mar 2023

Surgical resection of a giant cardiac angiosarcoma and reconstruction of involved right heart structures: A case report

in Cardio-Oncology

Andreea Blindaru
Alexandru Vasilescu
Andrei Danet
Oana Zimnicaru
Maximilian Cristu
Stefan Tudorica
Tudor Borjog
Oana Patrascu
Catalin Constantin Badiu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1115962

1,374 views

General Commentary

Published on 27 Feb 2023

Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”

in Cardio-Oncology

Louise Y. Sun
Gift Echefu
Krishna Doshi
Michelle L. Roberts
Abdulaziz Hamid
Richard K. Cheng
Jessica Olson
Sherry-Ann Brown

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.982028

1,615 views
1 citation

Mini Review

Published on 21 Feb 2023

Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal

in Cardio-Oncology

Massimiliano Camilli
Luca Maggio
Lorenzo Tinti
Priscilla Lamendola
Gaetano Antonio Lanza
Filippo Crea
Antonella Lombardo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1090103

3,444 views
9 citations

Review

Published on 17 Feb 2023

Galectin functions in cancer-associated inflammation and thrombosis

in Cardio-Oncology

Linus Kruk
Attila Braun
Erika Cosset
Thomas Gudermann
Elmina Mammadova-Bach

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1052959

5,754 views
10 citations

Case Report

Published on 15 Feb 2023

A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole

in Cardio-Oncology

Yuting Yuan
Chunjian Wang
Hongying Yao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.984572

2,319 views
4 citations

Study Protocol

Published on 10 Feb 2023

Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer–The EARLY-MYO-BC study

in Cardio-Oncology

Yezi Chai
Meng Jiang
Yaohui Wang
Qiming Liu
Qifan Lu
Zhengyu Tao
Qizhen Wu
Wenjin Yin
Jinsong Lu
Jun Pu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1021937

2,494 views
2 citations

Case Report

Published on 09 Feb 2023

Case report: The diagnostic challenge of primary cardiac intimal sarcoma

in Cardio-Oncology

Naili Ye
Lan Lan
Huijuan Hu
Jinping Liu
Haibo Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1089636

2,308 views
4 citations

Navigation group

Articles

Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience

Early detection and serial monitoring during chemotherapy-radiation therapy: Using T1 and T2 mapping cardiac magnetic resonance imaging

Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity

Case report: Diagnosis, management and evolution of a bulky and invasive cardiac mass complicated by complete atrioventricular block

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity

Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022

Association between thyroid cancer and cardiovascular disease: A meta-analysis

Surgical resection of a giant cardiac angiosarcoma and reconstruction of involved right heart structures: A case report

Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”

Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal

Galectin functions in cancer-associated inflammation and thrombosis

A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole

Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer–The EARLY-MYO-BC study

Case report: The diagnostic challenge of primary cardiac intimal sarcoma